S 708
118th Congress
Senate
Health
Drug therapy
Medicaid
Mental health
Prescription drugs
State and local government operations
A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 8, 2023
Read twice and referred to the Committee on Finance.
Mar 8, 2023
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
This bill requires the Centers for Medicare & Medicaid Services to issue guidance for state Medicaid programs on best practices to support individuals with major depressive disorder or other mental health conditions, including options that include pharmacogenetic testing.
What's happening now
Read twice and referred to the Committee on Finance.
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
2
Cite this page
U.S. Congress. (2026). S. 708: A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.. 118th Congress. Open America. https://openamerica.io/bill/118-S-708/
"S. 708: A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-708/.
S. 708, 118th Cong. (2026), https://openamerica.io/bill/118-S-708/.
[S. 708: A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.](https://openamerica.io/bill/118-S-708/)